Finder makes money from featured partners, but editorial opinions are our own. Advertiser disclosure

How to buy ProShares Ultra Nasdaq Biotechnology stock (BIB)

Buy ProShares Ultra Nasdaq Biotechnology stock in 5 easy steps, view past price performance and learn what’s ahead for the company.

ProShares Ultra Nasdaq Biotechnology is a n/a business based in the US. ProShares Ultra Nasdaq Biotechnology shares (BIB) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $51.41 – a decrease of 7.2% over the previous week. ProShares Ultra Nasdaq Biotechnology employs 0 staff and has a trailing 12-month revenue of around .

Our top picks for where to buy ProShares Ultra Nasdaq Biotechnology stock

Top pick for advanced traders

Go to site
  • Trade options, futures, options on futures, stocks, ETFs
  • $0 commission to close options
  • Pro-grade platform and risk analysis tools

Our pick for investing by theme

Go to site
  • Trade $0 commission stocks & ETFs with as little as $1
  • Earn up to $300 with qualifying deposits
  • Discover new opportunities with Opto's AI-driven thematic investing system
  • Theme and ETF screener

Our pick for stock bonuses

Go to site
  • Trade stocks, options, ETFs, mutual funds, alternative asset funds
  • $0 commission on stocks, ETFs and options with no options contract fees
  • Get up to $1,000 in stock when you fund a new account within 30 days
  • Complimentary access to a financial planner
Probability of member receiving $1,000 is 0.028%

How to buy ProShares Ultra Nasdaq Biotechnology stock

  1. Choose a stock trading platform. Use our comparison table
  2. Open an account. Provide your personal information and sign up.
  3. Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
  4. Search for the stock name – BIB. Search for the stock by name or ticker symbol.
  5. Buy the stock. Place your order. It's that simple.

Buy ProShares Ultra Nasdaq Biotechnology stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.
1 - 4 of 4
Product USFST Finder Score Available asset types Stock trade fee Minimum deposit Cash sweep APY Signup bonus
Finder score
Stocks, Options, ETFs, Cryptocurrency, Futures, Treasury Bills
$0
$0
N/A
Get $50-$5,000
Finder score
Stocks, ETFs
$0
$0
N/A
Earn up to $300
Finder score
Stocks, Options, Mutual funds, ETFs, Alternatives
$0
$0
0.02%
Get up to $1,000 in stock
Finder score
Stocks, Bonds, Options, ETFs, Cryptocurrency, Alternatives, Treasury Bills, High-yield cash account
$0
$0
4.35%
Get up to $10,000 and transfer fees covered
loading

What is the Finder Score?

The Finder Score crunches 147 key metrics we collected directly from 18+ brokers and assessed each provider’s performance based on nine different categories, weighing each metric based on the expertise and insights of Finder’s investment experts. We then scored and ranked each provider to determine the best brokerage accounts.

We update our best picks as products change, disappear or emerge in the market. We also regularly review and revise our selections to ensure our best provider lists reflect the most competitive available.

Read the full Finder Score breakdown

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

ProShares Ultra Nasdaq Biotechnology stock price (NASDAQ: BIB)

Use our graph to track the performance of BIB stocks over time.

ProShares Ultra Nasdaq Biotechnology shares at a glance

Information last updated 2024-12-19.
Latest market close$51.41
52-week range$46.88 - $69.39
50-day moving average $60.38
200-day moving average $59.93
Wall St. target priceN/A
PE ratio N/A
Dividend yield N/A
Earnings per share (TTM) N/A

Is it a good time to buy ProShares Ultra Nasdaq Biotechnology stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

ProShares Ultra Nasdaq Biotechnology price performance over time

Historical closes compared with the close of $51.41 from 2024-12-20

1 week (2024-12-16) -7.20%
1 month (2024-11-22) -9.55%
3 months (2024-09-23) -20.18%
6 months (2024-06-21) -13.29%
1 year (2023-12-22) -6.61%
2 years (2022-12-23) -11.04%
3 years (2021-12-23) 84.1655
5 years (2019-12-23) 63.6596

ProShares Ultra Nasdaq Biotechnology share dividends

Dividend payout ratio: % of net profits

Recently ProShares Ultra Nasdaq Biotechnology has paid out, on average, around 0% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), ProShares Ultra Nasdaq Biotechnology shareholders could enjoy a 0% return on their shares, in the form of dividend payments. In ProShares Ultra Nasdaq Biotechnology's case, that would currently equate to about $N/A per share.

ProShares Ultra Nasdaq Biotechnology's payout ratio would broadly be considered high, and as such this stock could appeal to those looking to generate an income. Bear in mind however that companies should normally also look to re-invest a decent amount of net profits to ensure future growth.

ProShares Ultra Nasdaq Biotechnology share price volatility

Over the last 12 months, ProShares Ultra Nasdaq Biotechnology's shares have ranged in value from as little as $46.8801 up to $69.3935. A popular way to gauge a stock's volatility is its "beta".

BIB.US volatility(beta: 1.36)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while ProShares Ultra Nasdaq Biotechnology's is 1.36. This would suggest that ProShares Ultra Nasdaq Biotechnology's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

ProShares Ultra Nasdaq Biotechnology overview

The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the Daily Target. The index is a modified capitalization weighted index that includes securities of Nasdaq listed companies that are classified as either biotechnology or pharmaceutical. The fund is non-diversified. .

Frequently asked questions

What percentage of ProShares Ultra Nasdaq Biotechnology is owned by insiders or institutions?
Currently N/A% of ProShares Ultra Nasdaq Biotechnology shares are held by insiders and N/A% by institutions.
How many people work for ProShares Ultra Nasdaq Biotechnology?
Latest data suggests 0 work at ProShares Ultra Nasdaq Biotechnology.

More guides on Finder

Ask a question

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Go to site